Two Sigma Advisers LP raised its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 61.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 944,000 shares of the company's stock after acquiring an additional 358,400 shares during the period. Two Sigma Advisers LP owned about 1.90% of Nu Skin Enterprises worth $6,504,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Susquehanna International Group LLP increased its stake in shares of Nu Skin Enterprises by 191.9% in the fourth quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock worth $4,838,000 after buying an additional 461,608 shares during the period. D. E. Shaw & Co. Inc. grew its holdings in Nu Skin Enterprises by 15.5% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 2,251,352 shares of the company's stock worth $15,512,000 after purchasing an additional 301,295 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Nu Skin Enterprises by 74.9% in the 4th quarter. JPMorgan Chase & Co. now owns 405,667 shares of the company's stock worth $2,795,000 after purchasing an additional 173,710 shares in the last quarter. Two Sigma Investments LP boosted its holdings in Nu Skin Enterprises by 24.2% in the fourth quarter. Two Sigma Investments LP now owns 700,500 shares of the company's stock worth $4,826,000 after acquiring an additional 136,624 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in Nu Skin Enterprises by 115.1% during the 4th quarter. Ameriprise Financial Inc. now owns 238,237 shares of the company's stock valued at $1,641,000 after purchasing an additional 127,474 shares during the last quarter. Institutional investors own 82.84% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Monday, May 12th.
Check Out Our Latest Stock Analysis on NUS
Nu Skin Enterprises Price Performance
Shares of NUS stock traded up $0.31 during mid-day trading on Tuesday, hitting $7.57. The company had a trading volume of 564,537 shares, compared to its average volume of 833,004. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The stock's 50 day moving average price is $6.58 and its 200-day moving average price is $7.03. Nu Skin Enterprises, Inc. has a 52-week low of $5.32 and a 52-week high of $13.90. The company has a market capitalization of $374.06 million, a P/E ratio of -2.57 and a beta of 0.92.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.08. The firm had revenue of $364.49 million during the quarter, compared to analyst estimates of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. Equities research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.
Nu Skin Enterprises Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 3.17%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises's payout ratio is -30.00%.
Nu Skin Enterprises Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.